Oragenics, Inc. (OGEN)
0.201
-0.15
(-42.59%)
USD |
NYAM |
Nov 13, 16:00
0.2061
+0.01
(+2.54%)
After-Hours: 19:59
Oragenics Shareholders Equity (Quarterly) : 1.092M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.092M |
| June 30, 2026 | 3.671M |
| March 31, 2026 | 6.182M |
| December 31, 2025 | 8.281M |
| September 30, 2025 | 9.831M |
| June 30, 2025 | -2.128M |
| March 31, 2025 | 0.1377M |
| December 31, 2024 | -0.2119M |
| September 30, 2024 | 3.078M |
| June 30, 2024 | 1.326M |
| March 31, 2024 | 2.625M |
| December 31, 2023 | 3.168M |
| September 30, 2023 | 6.497M |
| June 30, 2023 | 7.258M |
| March 31, 2023 | 10.24M |
| December 31, 2022 | 13.01M |
| September 30, 2022 | 15.27M |
| June 30, 2022 | 16.79M |
| March 31, 2022 | 21.99M |
| December 31, 2021 | 26.49M |
| September 30, 2021 | 28.55M |
| June 30, 2021 | 32.73M |
| March 31, 2021 | 36.05M |
| December 31, 2020 | 16.84M |
| September 30, 2020 | 9.640M |
| Date | Value |
|---|---|
| June 30, 2020 | 8.788M |
| March 31, 2020 | 12.91M |
| December 31, 2019 | 17.23M |
| September 30, 2019 | 20.82M |
| June 30, 2019 | 24.42M |
| March 31, 2019 | 29.12M |
| December 31, 2018 | 20.88M |
| September 30, 2018 | 13.98M |
| June 30, 2018 | 3.651M |
| March 31, 2018 | 4.315M |
| December 31, 2017 | 6.316M |
| September 30, 2017 | 1.013M |
| June 30, 2017 | 0.5055M |
| March 31, 2017 | 1.186M |
| December 31, 2016 | 2.996M |
| September 30, 2016 | 5.502M |
| June 30, 2016 | 7.239M |
| March 31, 2016 | 2.874M |
| December 31, 2015 | 4.731M |
| September 30, 2015 | 1.503M |
| June 30, 2015 | 3.094M |
| March 31, 2015 | 9.156M |
| December 31, 2014 | 10.34M |
| September 30, 2014 | 11.56M |
| June 30, 2014 | 12.56M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Candel Therapeutics, Inc. | 131.59M |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.282M |
| Total Liabilities (Quarterly) | 2.189M |
| Debt to Equity Ratio | 0.363 |
| Current Ratio | 1.499 |
| Net Debt Paydown Yield | 23.46% |